Wednesday 4 August 2021
Home      All news      Contact us      RSS      India
business-standard - 14 days ago

Optimus announces Interim Clinical Results from Phase III Clinical Trials of Molnupiravir conducted in India

Hyderabad (Telangana) [India], July 21 (ANI/PNN): Optimus Pharma on Sunday submitted the interim result of Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild Covid-19 patients.


Latest News
Hashtags:   

Optimus

 | 

announces

 | 

Interim

 | 

Clinical

 | 

Results

 | 

Phase

 | 

Clinical

 | 

Trials

 | 

Molnupiravir

 | 

conducted

 | 

India

 | 

Sources